{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:33:19Z","timestamp":1790634799649,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.ajo.2006.02.018","type":"journal-article","created":{"date-parts":[[2006,7,7]],"date-time":"2006-07-07T00:00:22Z","timestamp":1152230422000},"page":"46-59.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Retinopathy of Prematurity: Two Distinct Mechanisms That Underlie Zone 1 and Zone 2 Disease"],"prefix":"10.1016","volume":"142","author":[{"given":"John T.","family":"Flynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tailoi","family":"Chan-Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2006.02.018_bib1","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archopht.1984.01040030908011","article-title":"An international classification of retinopathy of prematurity","volume":"102","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/archopht.1987.01060070042025","article-title":"An international classification of retinopathy of prematurity","volume":"105","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib3","first-page":"1217","article-title":"Vascularisation of the human fetal retina","volume":"41","author":"Hughes","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2006.02.018_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/archopht.1990.01070040047029","article-title":"Multicenter trial of retinopathy of prematurity","volume":"108","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.105.2.295","article-title":"Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (Stop ROP), a randomized clinical trial","volume":"105","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajo.2006.02.018_bib6","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indication for the treatment of retinopathy of prematurity","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/oxfordjournals.bmb.a070758","article-title":"Retinal angiogenesis in the human embryo","volume":"26","author":"Ashton","year":"1970","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ajo.2006.02.018_bib8","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1167\/iovs.03-1169","article-title":"Astrocyte-endothelial cell relationships during human retinal vascular development","volume":"45","author":"Chan-Ling","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2006.02.018_bib9","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF165) expression by neuroglia","volume":"15","author":"Stone","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajo.2006.02.018_bib10","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1096\/fj.00-0868fje","article-title":"Astrocyte precursor cell (APCs) and astrocyte differentiation in embryonic human retina","volume":"15","author":"Chu","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.ajo.2006.02.018_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/cne.903130405","article-title":"Structure of the macroglia of the retina","volume":"313","author":"Holl\u00e4nder","year":"1991","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.ajo.2006.02.018_bib12","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1167\/iovs.03-1312","article-title":"Characterization of smooth muscle cells and pericyte differentiation in the rat retina in vivo","volume":"45","author":"Hughes","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2006.02.018_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/1350-9462(94)90015-9","article-title":"Glial, neuronal and vascular interactions in the mammalian retina","volume":"13","author":"Chan-Ling","year":"1994","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2006.02.018_bib14","unstructured":"Chan-Ling T, Hughes S. Cell-cell interactions in the formation of the human retinal vasculature. Mol Vis (Forthcoming)."},{"key":"10.1016\/j.ajo.2006.02.018_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1542\/peds.2004-2695","article-title":"Annual summary of vital statistics","volume":"115","author":"Martin","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajo.2006.02.018_bib16","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0161-6420(79)35328-3","article-title":"A classification of retrolental fibroplasia to evaluate vitamin E therapy","volume":"86","author":"Schaffer","year":"1979","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.02.018_bib17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/0002-9394(82)90298-7","article-title":"A revised classification of retinopathy of prematurity","volume":"94","author":"Quinn","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib18","series-title":"Multicenter trial of cryotherapy for retinopathy of prematurity","year":"1985"},{"key":"10.1016\/j.ajo.2006.02.018_bib19","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/archopht.121.11.1563","article-title":"Asymmetric location of retinopathy of prematurity in the nasal and temporal retina","volume":"121","author":"Gallagher","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000116602","article-title":"Development of the retinofugal pathway in birds and mammals","volume":"31","author":"Dreher","year":"1988","journal-title":"Brain Behav Evol"},{"key":"10.1016\/j.ajo.2006.02.018_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0278-4327(93)90008-H","article-title":"Retinopathy of prematurity","volume":"12","author":"Chan-Ling","year":"1993","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2006.02.018_bib22","first-page":"1201","article-title":"The effect of oxygen on vasoformative cell division","volume":"36","author":"Chan-Ling","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2006.02.018_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1006\/exer.1997.0365","article-title":"Development of the human retinal vasculature","volume":"65","author":"Provis","year":"1997","journal-title":"Exper Eye Res"},{"key":"10.1016\/j.ajo.2006.02.018_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/cne.902330403","article-title":"Development of the human retina","volume":"233","author":"Provis","year":"1985","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.ajo.2006.02.018_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/380435a0","article-title":"Abnormal blood vessel development and lethality in embryos lacking a single VEGF165 allele","volume":"380","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ajo.2006.02.018_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/380439a0","article-title":"Heterozygous embryonic lethality induced by targeted inactivation of the VEGF165 gene","volume":"380","author":"Ferrara","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ajo.2006.02.018_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0002-9394(71)91301-8","article-title":"Ophthalmoscopic monitoring of oxygen therapy in premature infants","volume":"72","author":"Cantolino","year":"1971","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib28","series-title":"Fluorescein Angiography","first-page":"155","article-title":"Fluorescein angiography in the study of retrolental fibroplasia","author":"O\u2019Grady","year":"1974"},{"key":"10.1016\/j.ajo.2006.02.018_bib29","first-page":"144","article-title":"Retrolental fibroplasia","volume":"12","author":"O\u2019Grady","year":"1974","journal-title":"Mod Probl Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00417113","article-title":"Acute proliferative retrolental fibroplasia","volume":"195","author":"Flynn","year":"1975","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archopht.1977.04450020019002","article-title":"Retrolental fibroplasia","volume":"95","author":"Flynn","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archopht.1977.04450010031002","article-title":"Retrolental fibroplasia","volume":"95","author":"Kushner","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib33","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0161-6420(79)35329-5","article-title":"Fluorescein angiography in retrolental fibroplasia","volume":"86","author":"Flynn","year":"1979","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.02.018_bib34","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJM199204163261603","article-title":"A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity","volume":"326","author":"Flynn","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2006.02.018_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bjo.38.7.385","article-title":"Pathologic basis of retrolental fibroplasia","volume":"38","author":"Ashton","year":"1954","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1442-9071.2000.00226.x","article-title":"Vitreal macrophages express VEGF165 in oxygen-induced retinopathy","volume":"28","author":"Naug","year":"2000","journal-title":"Clin Exper Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited","volume":"123","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archopht.1996.01100130144005","article-title":"Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity","volume":"114","author":"Kivlin","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.02.018_bib39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography after an intravitreal injection of bevacizumab","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.ajo.2006.02.018_bib40","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ophtha.2005.02.007","article-title":"Systemic bevacizumab therapy for neovascular age-related macular degeneration","volume":"112","author":"Michels","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.02.018_bib41","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s00467-005-1911-z","article-title":"Problems in classifying vasculitis in children","volume":"20","author":"Ozen","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ajo.2006.02.018_bib42","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/sj.leu.2403950","article-title":"Dual tyrosine kinase inhibitors in chronic myelogenous leukemia","volume":"19","author":"Martinelli","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.ajo.2006.02.018_bib43","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.193.12.1383","article-title":"c-Abl is required for the development of hyperoxia-induced retinopathy","volume":"193","author":"Nunes","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajo.2006.02.018_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.earlhumdev.2004.06.003","article-title":"Hypoxic-ischemic brain injury in the term infant","volume":"80","author":"Shalak","year":"2004","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajo.2006.02.018_bib45","first-page":"137","article-title":"The mode of development of the vascular system of the retina with some observations on its significance for certain retinal diseases","volume":"68","author":"Michaelson","year":"1948","journal-title":"Trans Ophthalmol Soc UK"},{"key":"10.1016\/j.ajo.2006.02.018_bib46","first-page":"465","article-title":"Doyne memorial lecture","volume":"83","author":"Cogan","year":"1963","journal-title":"Trans Ophthalmol Soc UK"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939406002613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939406002613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:52:33Z","timestamp":1757595153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939406002613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0002939406002613"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2006.02.018","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinopathy of Prematurity: Two Distinct Mechanisms That Underlie Zone 1 and Zone 2 Disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2006.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}